Mediterranean diet and insulin pump in type 1 diabetes
Part of Hormones & metabolism clinical trials.
This trial tests whether following a Mediterranean diet can improve blood sugar control and insulin use in people with type 1 diabetes who are starting a new insulin pump (MiniMed 780G). It compares how diet affects glucose levels and insulin needs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with type 1 diabetes for more than 1 year
- Your most recent HbA1c (average blood sugar) is less than 12.5%
- You are at least 7 years old
- You currently take multiple daily insulin injections and use more than 8 units of insulin per day
- You are ready to start using the MiniMed 780G insulin pump
- You have had at least 3 doctor visits in the past year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new insulin pump system (MiniMed 780G) in children aged 7-17 who were recently diagnosed with type 1 diabetes. It aims to see if this pump helps control blood sugar better and improves quality of life compared to standard insulin shots or older pumps.
This study is looking at how keeping your blood sugar in a healthy range (called 'time in range') affects the health of your blood vessels and heart in people with type 1 diabetes. It uses a special automated insulin delivery system to help you stay in range.
This trial is testing the best timing for bolus insulin doses (before vs. during a meal) in people using the MiniMed 780G pump. It may help you learn how to better manage your blood sugar after meals.
This study tests an insulin pump to help people with type 1 diabetes keep their blood sugar in a healthy range more of the time. You'll wear the pump and share weekly data with the study team.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This study tests a new experimental automated insulin delivery system for people with type 1 or type 2 diabetes who already use a specific insulin pump (MiniMed 780G with Simplera Sync sensor). The goal is to see if the new system is safe and works well to help manage blood sugar.
Hear when a new Type1diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.